Molzym has developed Sepsitest, a PCR test for early and rapid diagnosis of sepsis.
Sepsis (blood poisoning) is a systemic inflammation of the whole body ultimately leading to multiple organ dysfunction.
In less than four hours the broad-spectrum screening assay detects more than 345 relevant sepsis germs, allowing highly targeted antibiotic therapy.
Today's conventional microbiological methods deliver results, on average, after 48 hours.
Sepsitest received CE-IVD marking according to European in-vitro diagnostic law and is now available for routine sepsis diagnostics.
Research from Sepnet, the European sepsis network, showed dramatically increased survival rates for sepsis patients receiving early and targeted antibiotic treatment.
